Hexahydrocurcumin structure
|
Common Name | Hexahydrocurcumin | ||
---|---|---|---|---|
CAS Number | 36062-05-2 | Molecular Weight | 374.427 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 622.6±55.0 °C at 760 mmHg | |
Molecular Formula | C21H26O6 | Melting Point | 80-82℃ | |
MSDS | Chinese USA | Flash Point | 218.4±25.0 °C |
Use of HexahydrocurcuminHexahydrocurcumin is a natural compound which posesses anticancer and anti-inflammatory activities; selective COX-2 inhibitor.IC50 value:Target: in vitro: The relative antioxidant potencies of ginger compounds decreased in similar order of 1-dehydro-[6]-gingerdione, hexahydrocurcumin>6-shogaol>6-dehydroshogaol in both 1,1-diphenyl-2-picyrlhydrazyl (DPPH) radical-scavenging and trolox equivalent antioxidant capacity (TEAC) assays [1]. HHC alone markedly decreased the viability of HT-29 human colon cancer cells compared to control. HHC significantly down-regulates COX-2 mRNA expression compared to the control (control: 100.05% ± 0.03% vs HHC: 61.01% ± 0.35%, P < 0.05) but does not alter COX-1 mRNA. In combined treatment, addition of HHC to a low dose of 5-FU exerts a synergistic effect against the growth of HT-29 cells by markedly reducing cell viability to a greater degree than monotherapy [2].in vivo: The combined effects of HHC with 5-FU exhibit a synergistic inhibition by decreasing ACF formation mediated by down-regulation of COX-2 expression in rats [3]. |
Name | Hexahydrocurcumin |
---|---|
Synonym | More Synonyms |
Description | Hexahydrocurcumin is a natural compound which posesses anticancer and anti-inflammatory activities; selective COX-2 inhibitor.IC50 value:Target: in vitro: The relative antioxidant potencies of ginger compounds decreased in similar order of 1-dehydro-[6]-gingerdione, hexahydrocurcumin>6-shogaol>6-dehydroshogaol in both 1,1-diphenyl-2-picyrlhydrazyl (DPPH) radical-scavenging and trolox equivalent antioxidant capacity (TEAC) assays [1]. HHC alone markedly decreased the viability of HT-29 human colon cancer cells compared to control. HHC significantly down-regulates COX-2 mRNA expression compared to the control (control: 100.05% ± 0.03% vs HHC: 61.01% ± 0.35%, P < 0.05) but does not alter COX-1 mRNA. In combined treatment, addition of HHC to a low dose of 5-FU exerts a synergistic effect against the growth of HT-29 cells by markedly reducing cell viability to a greater degree than monotherapy [2].in vivo: The combined effects of HHC with 5-FU exhibit a synergistic inhibition by decreasing ACF formation mediated by down-regulation of COX-2 expression in rats [3]. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 622.6±55.0 °C at 760 mmHg |
Melting Point | 80-82℃ |
Molecular Formula | C21H26O6 |
Molecular Weight | 374.427 |
Flash Point | 218.4±25.0 °C |
Exact Mass | 374.172943 |
PSA | 96.22000 |
LogP | 1.49 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |
Index of Refraction | 1.583 |
Storage condition | -20°C |
RIDADR | NONH for all modes of transport |
---|---|
HS Code | 2914509090 |
HS Code | 2914509090 |
---|---|
Summary | HS:2914509090 other ketones with other oxygen function VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
Hexahydrocurcumin |
5-Hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)heptan-3-one |
5-Hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-3-heptanone |
(RS)-5-Hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-3-heptanone |
3-Heptanone, 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)- |